|
|
|
|
|
|
by mft_
480 days ago
|
|
|
That was a concern in the early days of development of anti PD(L)-1 agents - that chemo and even steroids would harm the T-cells you’re trying to activate. Yet there are settings where a deliberate combination of anti PD-1 with chemotherapy is the standard of care. And there are other types of immunotherapy where a combination with chemotherapy is advantageous too. |
|
|